Task-orientated visual satisfaction evaluation could help lens design selection

Article

Using a task-orientated visual satisfaction evaluation has potential to help in lens design selection and predicting wearing success.

Using a task-orientated visual satisfaction evaluation has potential to help in lens design selection and predicting wearing success, according to a paper in Journal of Optometry.

Dr Joan Gispets et al., University Vision Centre, Universitat Politècnica de Catalunya, Terrassa, Barcelona, Spain, completed a longitudinal prospective, cross-over, double-masked study on 22 presbyopic patients were randomly and alternatively fitted with two types of multifocal lenses.

The patients followed two 14-day trial periods, after which overall satisfaction was evaluated. The wearing success of the lens was assessed via the percentage of subjects choosing to continue wearing a multifocal lens and by the total number of subjects continuing to wear the lenses six months later. Habitual tasks were identified by observation distance, visual demand level and time allocation.

Visual satisfaction was affected by viewing distance and visual demand level. It decreased when tasks required higher visual demands involving near and far distance vision, compared to intermediate vision or a combination of near and far vision. It was found that the main reason for patient discontinuation of multifocal lenses was due to insufficient quality of vision.

Finally, 78% of the patients included in the study chose to continue wearing the lenses, with 1 patient deciding to wear them daily 6 months after study completion. The investigation suggests that a task-orientated visual satisfaction evaluation could be beneficial towards the design selection of a patient's lens and the determination of wearing success.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.